Afferent Pharmaceuticals Investors

27 investors on Angel Roster list Afferent Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Afferent Pharmaceuticals can appear together.

Investors listed
27
With verified email
33%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 27 Afferent Pharmaceuticals investors

The most complete profiles first. Showing 27 of 27.

  • Brian HalakVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 61 more

    Verified email available

  • Christoph LengauerVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Craig MuirVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Robert TepperVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Daniel OmsteadVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more

    Verified email available

  • Eckard WeberVerified

    Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 53 more

    Verified email available

  • Jim BlairVerified

    Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 53 more

    Verified email available

  • Noreen RizviVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Rob FaulknerVerified

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • Ron HuntVerified

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Verified email available

  • Abbie Celniker

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more

    Contact details available

  • Cary Pfeffer

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • George Xu

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Jesse Treu

    Venture Capital, Founder, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 55 more

    Contact details available

  • Mark Levin

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceEducation

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Neil Exter

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Craig Slutzkin

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Gerard van Hamel Platerink

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • James Niedel

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Jason Akus

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more

    Contact details available

  • Jeffrey Ives

    Venture Capital · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Kelly Moynihan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Rebecca Luse

    Venture Capital · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Vijay Lathi

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Walter Kowtoniuk

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • William Motley

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Liam Ratcliffe

    Venture Capital, Angel/Individual, Investment Partner · United States

    SeedHealth CareRetailBiotechnologyFinTech

    Portfolio: Afferent Pharmaceuticals, Shoopy, CuraSen Therapeutics, Deciphera Pharmaceuticals

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Afferent Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 27 Afferent Pharmaceuticals investors. 9 of them (33%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (27), Private Equity Firms (13) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Afferent Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Seed (11).

Where are Afferent Pharmaceuticals investors based?

Most are based in the United States (27).

Which companies have Afferent Pharmaceuticals investors backed?

The most-backed portfolio companies among them are CytomX Therapeutics (16), Nurix Therapeutics (14), Pliant Therapeutics (14), Blueprint Medicines (14) and Jounce Therapeutics (14).

How do I contact Afferent Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 27, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.